Invesco Ltd. Savara Inc Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Savara Inc stock. As of the latest transaction made, Invesco Ltd. holds 89,258 shares of SVRA stock, worth $195,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89,258
Previous 48,797
82.92%
Holding current value
$195,475
Previous $149,000
65.77%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SVRA
# of Institutions
142Shares Held
162MCall Options Held
54.8KPut Options Held
4.1K-
Nea Management Company, LLC Timonium, MD24.5MShares$53.6 Million6.43% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$38.5 Million16.36% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$27.1 Million8.25% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$25.1 Million2.0% of portfolio
-
Vestal Point Capital, LP New York, NY11MShares$24.1 Million2.18% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $250M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.